Continuous Glucose Monitoring Technology in the Perioperative Period During Cardiac Surgery

Sponsored by Yale University

Phase Quota
Phase N/A

This is an observational study of continuous glucose monitoring technology during cardiac surgery. The investigators would like to develop data for descriptive analysis of a comparison of continuous glucose monitoring with a gold standard under the conditions of cardiac surgery.

Study Start Date: August 2010

Estimated Completion Date: Not specified

Specialties: Cardiology: Cardiac Surgery Nursing: Cardiology Surgery: Cardiac Surgery Physician Assistant: Cardiology Practice Management: Technology


  • Device: Use of continuous glucose monitor during surgery. ( Medtronic Minimed Guardian REALTime Continuous Glucose Monitor)

Inclusion criteria

  • Competent adults scheduled for elective cardiac surgery

Exclusion criteria

  • Inability to consent, emergency surgery

Study Locations And Contact Information

  • Yale New Haven Hospital, New Haven Connecticut

Feature this Clinical Trial

Get your trial in front of 1000s of physicians and patients.
Visit to find out how you can feature this clinical trial.